Meetu Agarwal
Overview
Explore the profile of Meetu Agarwal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ali W, Agarwal M, Jamal S, Gangwar R, Sharma R, Mubarak M, et al.
Int J Biol Macromol
. 2024 Aug;
278(Pt 3):134652.
PMID: 39173789
Despite the WHO's recommended treatment regimen, challenges such as patient non-adherence and the emergence of drug-resistant strains persist with TB claiming 1.5 million lives annually. In this study, we propose...
2.
Tanweer S, Sharma T, Grover A, Agarwal M, Grover S
ACS Omega
. 2024 Aug;
9(31):33743-33750.
PMID: 39130601
A essential gene, ThyX (Rv2754c), plays a key role in intermediate metabolism and respiration by catalyzing the formation of dTMP and tetrahydrofolate from dUMP and methylenetetrahydrofolate. ThyX is present in...
3.
Agarwal M, Bhaskar A, Singha B, Mukhopadhyay S, Pahuja I, Singh A, et al.
Commun Biol
. 2024 Aug;
7(1):949.
PMID: 39107377
The limitations of TB treatment are the long duration and immune-dampening effects of anti-tuberculosis therapy. The Cell wall plays a crucial role in survival and virulence; hence, enzymes involved in...
4.
Pahuja I, Ghoshal A, Okieh A, Verma A, Negi K, Agarwal M, et al.
Microbiol Spectr
. 2024 May;
12(7):e0041224.
PMID: 38809023
The host immune responses play a pivotal role in the establishment of long-term memory responses, which effectively aids in infection clearance. However, the prevailing anti-tuberculosis therapy, while aiming to combat...
5.
Singh D, Sharma R, Jamal S, Agarwal M, Grover S, Batra J
Int J Biol Macromol
. 2024 Mar;
264(Pt 1):130614.
PMID: 38447849
Mycobacterium tuberculosis (Mtb) caseinolytic protease B (ClpB) is a chaperone possessing a unique ability to resolubilize the aggregated proteins in vivo. ClpB has been shown to be important for the...
6.
Ali W, Jamal S, Gangwar R, Ahmed F, Pahuja I, Sharma R, et al.
Microbes Infect
. 2023 Dec;
26(3):105284.
PMID: 38145750
The increasing prevalence of drug-resistant Tuberculosis (TB) is imposing extreme difficulties in controlling the TB infection rate globally, making treatment critically challenging. To combat the prevailing situation, it is crucial...
7.
Ali W, Jamal S, Gangwar R, Ahmed F, Sharma R, Agarwal M, et al.
Mol Inform
. 2023 Dec;
43(3):e202300284.
PMID: 38123523
Tuberculosis (TB) is the second leading cause of mortality after COVID-19, with a global death toll of 1.6 million in 2021. The escalating situation of drug-resistant forms of TB has...
8.
Sharma R, Muthu S, Agarwal M, Mehto N, Pahuja I, Grover A, et al.
Int J Biol Macromol
. 2023 Oct;
253(Pt 6):127208.
PMID: 37816464
With the advancements of high throughput computational screening procedures, drug repurposing became the privileged framework for drug discovery. The structure-based drug discovery is the widely used method of drug repurposing,...
9.
Sharma K, Ahmed F, Sharma T, Grover A, Agarwal M, Grover S
ACS Omega
. 2023 May;
8(20):17362-17380.
PMID: 37251185
The devastating impact of Tuberculosis (TB) has been a menace to mankind for decades. The World Health Organization (WHO) End TB Strategy aims to reduce TB mortality up to 95%...
10.
Negi K, Agarwal M, Pahuja I, Bhardwaj B, Rawat M, Bhaskar A, et al.
Oxf Open Immunol
. 2023 Apr;
4(1):iqad001.
PMID: 37051070
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes lethal coronavirus disease (COVID-19). SARS-CoV-2 has been the chief source of threat to public health and safety from 2019 to the...